Veri Medtech Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009
Period Ending	Mar '12 Mar 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Revenue	0.07	0.06	0.06	0.06
Revenue Growth (YoY)	17.03%	8.88%	-6.46%	-
Cost of Revenue	0.01	0.01	0.02	0.05
Gross Profit	0.06	0.05	0.04	0.01
Selling, General & Admin	0.1	0.09	0.07	0.09
Other Operating Expenses	-	0	-	-
Operating Expenses	0.1	0.09	0.07	0.09
Operating Income	-0.04	-0.04	-0.03	-0.08
Interest Expense	-0	-0.01	-0	-
EBT Excluding Unusual Items	-0.05	-0.05	-0.04	-0.08
Gain (Loss) on Sale of Assets	-0.3	-0.3	-	-
Pretax Income	-0.35	-0.35	-0.04	-0.08
Net Income	-0.35	-0.35	-0.04	-0.08
Net Income to Common	-0.35	-0.35	-0.04	-0.08
Shares Outstanding (Basic)	2	2	1	1
Shares Outstanding (Diluted)	2	2	1	1
Shares Change (YoY)	35.18%	35.18%	27.82%	-
EPS (Basic)	-0.18	-0.18	-0.03	-0.07
EPS (Diluted)	-0.18	-0.18	-0.03	-0.07
Gross Margin	82.30%	81.12%	63.06%	15.93%
Operating Margin	-57.06%	-61.49%	-53.89%	-118.74%
Profit Margin	-469.03%	-536.33%	-60.54%	-118.74%
EBITDA	-	-0.04	-	-
EBITDA Margin	-	-61.42%	-	-
D&A For EBITDA	-	0	-	-
EBIT	-0.04	-0.04	-0.03	-0.08
EBIT Margin	-57.06%	-61.49%	-53.89%	-118.74%
Advertising Expenses	-	0.03	0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.